Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

Clinical trial NCT00249873 · COMPLETED

Trial details

NCT number: NCT00249873
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation Vascular Risk

Start date: 2003-06-01
Primary completion: 2009-03-01
Enrollment: 7554

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.